RheumScope

Explore recommendations for lupus, lupus nephritis, rheumatoid arthritis, ANCA-associated vasculitis, psoriatic arthritis, and gout. Follow clinical pathways, compare recommendations from ACR, EULAR, and KDIGO, and review the evidence behind them.

Predicted Changes highlights possible future guidance, clearly separated from published recommendations.

Explore patient outcomes, cohort reports, the trial pipeline, and safety updates for CAR-T and related cell therapies in rheumatic disease. Filters and source citations help you examine the evidence at each level.

Explore US prices of FDA-indicated rheumatology drugs since 1996, with biologics and targeted therapies at the center. Compare list prices, Medicare and Medicaid payments, launch prices, and what patients pay out of pocket, and see how competition and biosimilar entry relate to price. Every value links to its public source.